PROCEPT BioRobotics EPS - Earnings per Share 2021-2025 | PRCT
PROCEPT BioRobotics eps - earnings per share from 2021 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| PROCEPT BioRobotics Annual EPS | |
|---|---|
| 2024 | $-1.75 |
| 2023 | $-2.24 |
| 2022 | $-1.96 |
| 2021 | $-3.63 |
| 2020 | $-14.47 |
| PROCEPT BioRobotics Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.45 |
| 2024-12-31 | $-0.34 |
| 2024-09-30 | $-0.40 |
| 2024-06-30 | $-0.50 |
| 2024-03-31 | $-0.51 |
| 2023-12-31 | $-0.54 |
| 2023-09-30 | $-0.51 |
| 2023-06-30 | $-0.56 |
| 2023-03-31 | $-0.63 |
| 2022-12-31 | $-0.63 |
| 2022-09-30 | $-0.51 |
| 2022-06-30 | $-0.43 |
| 2022-03-31 | $-0.39 |
| 2021-12-31 | $2.84 |
| 2021-09-30 | $-1.22 |
| 2021-06-30 | $-2.60 |
| 2021-03-31 | $-2.65 |
| 2020-12-31 | $0.00 |
| 2020-09-30 | $-2.77 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.206B | $0.225B |
| PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $198.309B | 86.86 |
| Thermo Fisher Scientific (TMO) | United States | $149.665B | 18.10 |
| Edwards Lifesciences (EW) | United States | $45.813B | 30.04 |
| Alcon (ALC) | Switzerland | $42.010B | 28.39 |
| IDEXX Laboratories (IDXX) | United States | $41.401B | 47.58 |
| DexCom (DXCM) | United States | $33.529B | 51.82 |
| IQVIA Holdings (IQV) | United States | $24.064B | 13.48 |
| STERIS (STE) | Ireland | $23.814B | 26.23 |
| Mettler-Toledo (MTD) | United States | $23.716B | 28.20 |
| Waters (WAT) | United States | $20.452B | 28.86 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.615B | 0.00 |
| Hologic (HOLX) | United States | $13.819B | 15.02 |
| Sysmex ADR (SSMXY) | Japan | $10.581B | 30.02 |
| Penumbra (PEN) | United States | $9.920B | 77.86 |
| Masimo (MASI) | United States | $8.948B | 33.01 |
| Globus Medical (GMED) | United States | $7.982B | 19.02 |
| Glaukos (GKOS) | United States | $5.416B | 0.00 |
| Teleflex (TFX) | United States | $5.288B | 8.73 |
| TransMedics (TMDX) | United States | $4.192B | 91.13 |
| Integer Holdings (ITGR) | United States | $4.106B | 21.52 |
| LivaNova (LIVN) | United Kingdom | $2.367B | 14.09 |
| Veracyte (VCYT) | United States | $2.094B | 29.39 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.19 |
| Elekta AB (EKTAY) | Sweden | $1.985B | 17.84 |
| Alphatec Holdings (ATEC) | United States | $1.798B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.226B | 114.84 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.957B | 5.09 |
| Beta Bionics (BBNX) | United States | $0.810B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.28 |
| RxSight (RXST) | United States | $0.631B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.568B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.534B | 12.53 |
| AxoGen (AXGN) | United States | $0.500B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| NeuroPace (NPCE) | United States | $0.428B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| AngioDynamics (ANGO) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.296B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.93 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.201B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.169B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.46 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |